INSIGHTS ON CLINICAL TRIAL DESIGN

• Overcoming Barriers To Clinical Trial Participation In Oncology

  Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.

• Eligibility Criteria For Successful Retinal Study Delivery

  Clear eligibility criteria drive retinal trial success. Explore how strategic design improves recruitment, safeguards data integrity, and meets compliance for studies on complex ocular conditions.

• The Latest Generation Of Patient Recruitment Has Arrived

  In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.

• Clinical Leader Smart Sourcing Solutions Expo: Mural Health Removing Barriers To Trial Participation

  Learn how one platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations worldwide.

• Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies

  6/5/2026

  See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.

• How Modern RTSM Platforms Are Eliminating Delays

  2/25/2026

  Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.

• Gene, Cell, And RNA Therapy Landscape Continues To Thrive

  3/21/2025

  The horizons of molecular medicine continued to expand in the Q4 2024, with pre-registration gene therapy programs up 83% from the third quarter.

• Choosing The Most Effective Method For Biopharmaceutical Development

  5/2/2025

  Explore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.

• The Hidden Financial Causes Of Patient Transportation Breakdowns In Clinical Trials

  6/15/2026

  Transport issues in trials often stem from fragmented financial workflows. Integrating payments with travel coordination reduces delays and supports reliable visits.